In recent years, public health experts worldwide have intensified efforts to combat cervical cancer, one of the deadliest yet most preventable cancers affecting women globally, through widespread use of the Human Papillomavirus (HPV) vaccine. As governments roll out vaccination campaigns and awareness grows, the vaccine’s role in saving lives and preventing multiple forms of cancer has never been more vital.
Understanding HPV and Its Global Impact
Human papillomavirus (HPV) is a group of viruses transmitted through skin‑to‑skin and sexual contact. While many HPV infections are harmless and resolve on their own, persistent infection with high‑risk HPV types can lead to cancer.
According to the World Health Organisation (WHO), cervical cancer remains the fourth most common cancer in women worldwide. In 2022, an estimated 660,000 new cases were diagnosed and around 350,000 deaths were attributed to the disease, nearly all of which could have been prevented with effective vaccination, screening, and treatment.
Globally, nearly 90% of new cervical cancer cases and deaths occur in low‑ and middle‑income countries, where access to vaccines and screening is limited.
In India, the burden is particularly heavy: approximately 1.2 lakh new cervical cancer cases are reported annually, and one woman reportedly dies every eight minutes from the disease.
HPV Vaccination: A Proven Prevention Tool
HPV vaccines, such as Gardasil and Cervarix, protect against the high‑risk HPV types that lead to most cases of cervical cancer. These vaccines are most effective when administered before exposure to the virus, ideally between ages 9 and 14.
Studies have shown that HPV immunization significantly lowers the risk of developing HPV‑related cancers in both sexes. One large study of more than 3.4 million people found that vaccinated individuals had markedly lower rates of HPV‑related cancers compared with those not vaccinated.
In the United States, data suggest a 62% reduction in cervical cancer deaths since the widespread adoption of HPV vaccination programs.
Efforts by global alliances, such as Gavi, the Vaccine Alliance, indicate that cervical cancer vaccines have already saved over 1 million lives in lower‑income countries and could prevent an estimated 1.4 million future deaths if access continues to expand.
Why Vaccination for Boys Matters?
Traditionally, HPV vaccination campaigns have focused on girls because of the strong link between HPV and cervical cancer. However, HPV can cause several other cancers and conditions that affect all genders:
-
Anal cancer, penile cancer, and head and neck cancers can all be caused by HPV infections, and some of these cancers are rising in incidence, particularly in men.
-
Research shows that HPV vaccination in boys and men significantly lowers the risk of these cancers, including oropharyngeal cancer (in the throat and tonsils).
-
HPV infections are common: nearly all sexually active individuals will be exposed at some point in their lives without vaccination.
Experts emphasize that vaccinating boys contributes to herd immunity, reducing overall virus circulation and protecting unvaccinated or vulnerable populations.
National and Regional Initiatives
Countries and states are taking action. Across India, regions like Andhra Pradesh and Telangana have launched or are preparing statewide HPV vaccination drives targeting adolescent girls, signaling a growing acceptance of vaccination as a key preventive measure.
The Indian Medical Association has begun a phased rollout of the HPV vaccine, initially focusing on healthcare workers’ families before expanding nationwide at subsidized rates from March 2026.
Addressing Barriers to Vaccination
Despite strong evidence supporting HPV vaccination, barriers remain. These include limited access in some regions, vaccine hesitancy driven by misinformation, affordability issues, and gaps in public health infrastructure. Health experts stress that concerted efforts are needed to improve awareness and expand coverage, especially in underserved communities.
The Road Ahead
HPV vaccination represents a milestone in modern cancer prevention, a tool with the potential not only to prevent the majority of cervical cancer deaths but also to protect against a broader range of HPV‑related cancers. By expanding vaccination to boys and girls alike and ensuring equitable access across populations, health authorities hope to move closer to the global elimination of HPV‑related cancers.
As governments and global partners push vaccination campaigns and public education, the message is clear: vaccination saves lives, and timely HPV immunization could be a defining factor in preventing countless deaths in the years to come.